Tag: personalized medicine
June 26, 2019
6 Top Genetic Testing Stocks
Looking to invest in genetic testing? Or learn more about the companies involved? Here are six genetic testing stocks to...
February 28, 2019
Innovation in Breast Cancer Treatment: Combination and Off-the-Shelf Personalized Immunotherapies
Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy December 6, 2018
Myriad Validates Polygenic Score to Predict Breast Cancer Risk
Myriad Genetics (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced results from an important study to validate the... November 2, 2018
Myriad Presents Two New Studies at the Western Section of the American Urological Association
Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, today announced new data from two studies presented at the Western... October 19, 2018
New Studies Highlight Performance of Vectra Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, today announced new data from two studies of Vectra that evaluated the... October 10, 2018
Myriad Announces New Laboratory Agreement with Pfizer
Myriad Genetics (NASDAQ:MYGN), a global leader in personalized medicine, announced today that it has signed a new laboratory services agreement...
June 28, 2018